English | Español
Patient Daily | Dec 21, 2025

Milestone wins FDA approval for nasal spray treating irregular heartbeat
Patient Daily | Dec 21, 2025

Sanofi and Dren Bio announce new autoimmune disease therapy partnership worth up to $1.7 billion
Patient Daily | Dec 21, 2025

Argenyx stops phase III trial after Vyvgart fails test for thyroid eye disease
Patient Daily | Dec 21, 2025

Immunome plans FDA submission after positive phase III data for desmoid tumor drug
Patient Daily | Dec 21, 2025

FDA set to decide on key drugs from GSK, Aldeyra, Rhythm before year-end
Patient Daily | Dec 21, 2025

Major clinical trial failures mark challenging year for biopharma companies
Patient Daily | Dec 21, 2025

Sanofi reports phase III failure and new FDA delay for MS drug
Patient Daily | Dec 21, 2025

Baylor College expert advises vigilance against holiday season scams targeting seniors

Trending
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
A. R. Baird | Jun 15, 2026

Health care reform group launches campaign linking consolidation to rising costs
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science